International Immunology, Vol. 16, No. 4, pp. 533-538,
April 2004
© 2004 Japanese Society for Immunology
FAST TRACK |
Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112)
1 Laboratory for Immune Receptor, RIKEN Research Center for Allergy and Immunology, RIKEN, Tsukuba, Ibaraki 305-0074, Japan 2 Department of Immunology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan 3 PRESTO, Japan Science and Technology Agency, Saitama 332-0012, Japan 4 Department of Microbiology and Immunology and the Cancer Research Institute, University of California San Francisco, San Francisco, CA 94143-0414, USA
Correspondence to: A. Shibuya, Department of Immunology, Institute of Basic Medical Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-3585, Japan. E-mail: ashibuya{at}md.tsukuba.ac.jp
Transmitting editor: K. Takatsu
CD226 (DNAM-1) is an adhesion molecule involved in NK and T cell-mediated cytotoxicity against certain tumors. Here, we have identified the human poliovirus receptor-related (PRR) family members CD155 [poliovirus receptor (PVR)] and CD112 (nectin-2/PRR-2) as the ligands for human CD226. Ectopic expression of human CD155 and/or CD112 rendered mouse BW5147 T cells more susceptible to IL-2-activated T and NK cell-mediated cytotoxicity, and killing was specifically inhibited by anti-CD226 mAb, demonstrating functional interactions of CD226 with CD155 and CD112. Although the binding affinities between soluble CD226 and CD155 or CD112 were comparable, the homophilic interaction of cell-surface CD112 may adversely affect CD226 binding to CD112. We also demonstrate that ligation of CD226 and LFA-1 with their respective ligands cooperates in triggering cytotoxicity and cytokine secretion by T and NK cells.
Keywords: adhesion molecule, cytotoxic T lymphocyte, cytotoxicity, NK cell, tumor immunity
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Iguchi-Manaka, H. Kai, Y. Yamashita, K. Shibata, S. Tahara-Hanaoka, S.-i. Honda, T. Yasui, H. Kikutani, K. Shibuya, and A. Shibuya Accelerated tumor growth in mice deficient in DNAM-1 receptor J. Exp. Med., December 22, 2008; 205(13): 2959 - 2964. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gilfillan, C. J. Chan, M. Cella, N. M. Haynes, A. S. Rapaport, K. S. Boles, D. M. Andrews, M. J. Smyth, and M. Colonna DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors J. Exp. Med., December 22, 2008; 205(13): 2965 - 2973. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bachelet, A. Munitz, D. Mankutad, and F. Levi-Schaffer Mast Cell Costimulation by CD226/CD112 (DNAM-1/Nectin-2): A NOVEL INTERFACE IN THE ALLERGIC PROCESS J. Biol. Chem., September 15, 2006; 281(37): 27190 - 27196. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Colonna Cytolytic responses: cadherins put out the fire J. Exp. Med., February 20, 2006; 203(2): 261 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tahara-Hanaoka, K. Shibuya, H. Kai, A. Miyamoto, Y. Morikawa, N. Ohkochi, S.-i. Honda, and A. Shibuya Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor Blood, February 15, 2006; 107(4): 1491 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Arase, A. Takeuchi, M. Unno, S. Hirano, T. Yokosuka, H. Arase, and T. Saito Heterotypic interaction of CRTAM with Necl2 induces cell adhesion on activated NK cells and CD8+ T cells Int. Immunol., September 1, 2005; 17(9): 1227 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Boles, W. Barchet, T. Diacovo, M. Cella, and M. Colonna The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM Blood, August 1, 2005; 106(3): 779 - 786. [Abstract] [Full Text] [PDF] |
||||



